nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—ABCC8—ATP sensitive Potassium channels—ABCC9—dilated cardiomyopathy	0.0829	0.267	CbGpPWpGaD
Glimepiride—KCNJ11—ATP sensitive Potassium channels—ABCC9—dilated cardiomyopathy	0.0804	0.259	CbGpPWpGaD
Glimepiride—CYP2C9—cardial valve—dilated cardiomyopathy	0.0456	0.761	CbGeAlD
Glimepiride—KCNJ1—Inwardly rectifying K+ channels—ABCC9—dilated cardiomyopathy	0.0315	0.102	CbGpPWpGaD
Glimepiride—Hypoglycemic reaction—Lisinopril—dilated cardiomyopathy	0.0304	0.0496	CcSEcCtD
Glimepiride—Gastrointestinal symptom NOS—Spironolactone—dilated cardiomyopathy	0.0231	0.0377	CcSEcCtD
Glimepiride—Drug eruption—Spironolactone—dilated cardiomyopathy	0.0221	0.0361	CcSEcCtD
Glimepiride—Glyburide—ABCC9—dilated cardiomyopathy	0.0178	1	CrCbGaD
Glimepiride—Diabetic—Lisinopril—dilated cardiomyopathy	0.0166	0.0271	CcSEcCtD
Glimepiride—ABCC8—Inwardly rectifying K+ channels—ABCC9—dilated cardiomyopathy	0.0161	0.0519	CbGpPWpGaD
Glimepiride—KCNJ11—Inwardly rectifying K+ channels—ABCC9—dilated cardiomyopathy	0.0156	0.0504	CbGpPWpGaD
Glimepiride—ABCC8—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.0143	0.0461	CbGpPWpGaD
Glimepiride—Vasculitis—Spironolactone—dilated cardiomyopathy	0.0139	0.0227	CcSEcCtD
Glimepiride—Cerebration impaired—Furosemide—dilated cardiomyopathy	0.0126	0.0205	CcSEcCtD
Glimepiride—KCNJ1—Potassium Channels—ABCC9—dilated cardiomyopathy	0.0125	0.0401	CbGpPWpGaD
Glimepiride—Drug eruption—Furosemide—dilated cardiomyopathy	0.012	0.0196	CcSEcCtD
Glimepiride—Eruption—Furosemide—dilated cardiomyopathy	0.012	0.0196	CcSEcCtD
Glimepiride—Cholestasis—Furosemide—dilated cardiomyopathy	0.00973	0.0159	CcSEcCtD
Glimepiride—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.00954	0.0156	CcSEcCtD
Glimepiride—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.00853	0.0139	CcSEcCtD
Glimepiride—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00844	0.0138	CcSEcCtD
Glimepiride—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0076	0.0124	CcSEcCtD
Glimepiride—Vasculitis—Furosemide—dilated cardiomyopathy	0.00757	0.0124	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00753	0.0123	CcSEcCtD
Glimepiride—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00709	0.0116	CcSEcCtD
Glimepiride—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00694	0.0113	CcSEcCtD
Glimepiride—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00645	0.0105	CcSEcCtD
Glimepiride—Mental disability—Furosemide—dilated cardiomyopathy	0.00641	0.0105	CcSEcCtD
Glimepiride—ABCC8—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00636	0.0205	CbGpPWpGaD
Glimepiride—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00627	0.0102	CcSEcCtD
Glimepiride—KCNJ11—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00617	0.0199	CbGpPWpGaD
Glimepiride—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00617	0.0101	CcSEcCtD
Glimepiride—KCNJ11—heart—dilated cardiomyopathy	0.00612	0.102	CbGeAlD
Glimepiride—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00594	0.00971	CcSEcCtD
Glimepiride—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00568	0.00928	CcSEcCtD
Glimepiride—ABCC8—heart—dilated cardiomyopathy	0.00564	0.0941	CbGeAlD
Glimepiride—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00561	0.00917	CcSEcCtD
Glimepiride—KCNJ1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00544	0.0175	CbGpPWpGaD
Glimepiride—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00539	0.0088	CcSEcCtD
Glimepiride—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00532	0.00868	CcSEcCtD
Glimepiride—KCNJ1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00521	0.0168	CbGpPWpGaD
Glimepiride—Confusional state—Spironolactone—dilated cardiomyopathy	0.00489	0.00798	CcSEcCtD
Glimepiride—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00485	0.00792	CcSEcCtD
Glimepiride—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00475	0.00775	CcSEcCtD
Glimepiride—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00467	0.00763	CcSEcCtD
Glimepiride—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00463	0.00756	CcSEcCtD
Glimepiride—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00461	0.00752	CcSEcCtD
Glimepiride—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00459	0.0075	CcSEcCtD
Glimepiride—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00448	0.00732	CcSEcCtD
Glimepiride—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00446	0.00728	CcSEcCtD
Glimepiride—Injury—Lisinopril—dilated cardiomyopathy	0.00438	0.00715	CcSEcCtD
Glimepiride—Somnolence—Spironolactone—dilated cardiomyopathy	0.00431	0.00704	CcSEcCtD
Glimepiride—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00428	0.007	CcSEcCtD
Glimepiride—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00423	0.00691	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00418	0.00684	CcSEcCtD
Glimepiride—Drowsiness—Furosemide—dilated cardiomyopathy	0.00413	0.00675	CcSEcCtD
Glimepiride—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00412	0.00674	CcSEcCtD
Glimepiride—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00411	0.00671	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.0041	0.0067	CcSEcCtD
Glimepiride—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00404	0.0066	CcSEcCtD
Glimepiride—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00403	0.00658	CcSEcCtD
Glimepiride—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00399	0.00652	CcSEcCtD
Glimepiride—Sweating—Furosemide—dilated cardiomyopathy	0.00396	0.00648	CcSEcCtD
Glimepiride—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00386	0.0063	CcSEcCtD
Glimepiride—Urticaria—Spironolactone—dilated cardiomyopathy	0.00385	0.00629	CcSEcCtD
Glimepiride—Visual impairment—Furosemide—dilated cardiomyopathy	0.00358	0.00584	CcSEcCtD
Glimepiride—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00357	0.00583	CcSEcCtD
Glimepiride—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00351	0.00573	CcSEcCtD
Glimepiride—Influenza—Lisinopril—dilated cardiomyopathy	0.00348	0.00568	CcSEcCtD
Glimepiride—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00344	0.00563	CcSEcCtD
Glimepiride—Pruritus—Spironolactone—dilated cardiomyopathy	0.00343	0.0056	CcSEcCtD
Glimepiride—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00339	0.00554	CcSEcCtD
Glimepiride—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00339	0.00554	CcSEcCtD
Glimepiride—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00332	0.00542	CcSEcCtD
Glimepiride—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00332	0.00542	CcSEcCtD
Glimepiride—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.0033	0.0054	CcSEcCtD
Glimepiride—Malnutrition—Furosemide—dilated cardiomyopathy	0.00323	0.00528	CcSEcCtD
Glimepiride—Erythema—Furosemide—dilated cardiomyopathy	0.00323	0.00528	CcSEcCtD
Glimepiride—Dizziness—Spironolactone—dilated cardiomyopathy	0.00321	0.00524	CcSEcCtD
Glimepiride—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00318	0.00519	CcSEcCtD
Glimepiride—Weight increased—Lisinopril—dilated cardiomyopathy	0.00317	0.00517	CcSEcCtD
Glimepiride—Vomiting—Spironolactone—dilated cardiomyopathy	0.00308	0.00503	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00308	0.00502	CcSEcCtD
Glimepiride—Rash—Spironolactone—dilated cardiomyopathy	0.00306	0.00499	CcSEcCtD
Glimepiride—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00305	0.00499	CcSEcCtD
Glimepiride—Vision blurred—Furosemide—dilated cardiomyopathy	0.00304	0.00497	CcSEcCtD
Glimepiride—Headache—Spironolactone—dilated cardiomyopathy	0.00304	0.00496	CcSEcCtD
Glimepiride—Jaundice—Lisinopril—dilated cardiomyopathy	0.00302	0.00494	CcSEcCtD
Glimepiride—Anaemia—Furosemide—dilated cardiomyopathy	0.00299	0.00488	CcSEcCtD
Glimepiride—Sweating—Lisinopril—dilated cardiomyopathy	0.00297	0.00486	CcSEcCtD
Glimepiride—Agitation—Furosemide—dilated cardiomyopathy	0.00297	0.00485	CcSEcCtD
Glimepiride—KCNJ11—Type II diabetes mellitus—TNF—dilated cardiomyopathy	0.00293	0.00944	CbGpPWpGaD
Glimepiride—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00289	0.00473	CcSEcCtD
Glimepiride—Leukopenia—Furosemide—dilated cardiomyopathy	0.00289	0.00472	CcSEcCtD
Glimepiride—Nausea—Spironolactone—dilated cardiomyopathy	0.00288	0.0047	CcSEcCtD
Glimepiride—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00284	0.00463	CcSEcCtD
Glimepiride—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00278	0.00455	CcSEcCtD
Glimepiride—ABCC8—Neuronal System—ABCC9—dilated cardiomyopathy	0.00278	0.00895	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—ABCC9—dilated cardiomyopathy	0.00269	0.00868	CbGpPWpGaD
Glimepiride—Dry mouth—Furosemide—dilated cardiomyopathy	0.00269	0.00439	CcSEcCtD
Glimepiride—ABCC8—Neuronal System—ACTN2—dilated cardiomyopathy	0.00266	0.00858	CbGpPWpGaD
Glimepiride—Confusional state—Furosemide—dilated cardiomyopathy	0.00266	0.00434	CcSEcCtD
Glimepiride—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00264	0.00431	CcSEcCtD
Glimepiride—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00263	0.0043	CcSEcCtD
Glimepiride—Shock—Furosemide—dilated cardiomyopathy	0.00259	0.00424	CcSEcCtD
Glimepiride—KCNJ11—Neuronal System—ACTN2—dilated cardiomyopathy	0.00258	0.00832	CbGpPWpGaD
Glimepiride—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00258	0.00422	CcSEcCtD
Glimepiride—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00255	0.00416	CcSEcCtD
Glimepiride—CYP2C9—heart—dilated cardiomyopathy	0.00252	0.0421	CbGeAlD
Glimepiride—Anorexia—Furosemide—dilated cardiomyopathy	0.00251	0.00411	CcSEcCtD
Glimepiride—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00249	0.00406	CcSEcCtD
Glimepiride—Hypotension—Furosemide—dilated cardiomyopathy	0.00246	0.00403	CcSEcCtD
Glimepiride—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00242	0.00396	CcSEcCtD
Glimepiride—Erythema—Lisinopril—dilated cardiomyopathy	0.00242	0.00396	CcSEcCtD
Glimepiride—Tension—Lisinopril—dilated cardiomyopathy	0.00238	0.00389	CcSEcCtD
Glimepiride—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00237	0.00387	CcSEcCtD
Glimepiride—Nervousness—Lisinopril—dilated cardiomyopathy	0.00235	0.00385	CcSEcCtD
Glimepiride—Somnolence—Furosemide—dilated cardiomyopathy	0.00234	0.00383	CcSEcCtD
Glimepiride—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00229	0.00374	CcSEcCtD
Glimepiride—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00228	0.00373	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00228	0.00372	CcSEcCtD
Glimepiride—Fatigue—Furosemide—dilated cardiomyopathy	0.00227	0.00371	CcSEcCtD
Glimepiride—Tremor—Lisinopril—dilated cardiomyopathy	0.00227	0.00371	CcSEcCtD
Glimepiride—Anaemia—Lisinopril—dilated cardiomyopathy	0.00224	0.00366	CcSEcCtD
Glimepiride—Angioedema—Lisinopril—dilated cardiomyopathy	0.00222	0.00362	CcSEcCtD
Glimepiride—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00217	0.00355	CcSEcCtD
Glimepiride—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00217	0.00354	CcSEcCtD
Glimepiride—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00216	0.00352	CcSEcCtD
Glimepiride—Palpitations—Lisinopril—dilated cardiomyopathy	0.00214	0.0035	CcSEcCtD
Glimepiride—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00213	0.00348	CcSEcCtD
Glimepiride—Urticaria—Furosemide—dilated cardiomyopathy	0.00209	0.00342	CcSEcCtD
Glimepiride—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00208	0.00341	CcSEcCtD
Glimepiride—Anxiety—Lisinopril—dilated cardiomyopathy	0.00206	0.00336	CcSEcCtD
Glimepiride—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00202	0.0033	CcSEcCtD
Glimepiride—Confusional state—Lisinopril—dilated cardiomyopathy	0.00199	0.00326	CcSEcCtD
Glimepiride—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00198	0.00323	CcSEcCtD
Glimepiride—Shock—Lisinopril—dilated cardiomyopathy	0.00195	0.00318	CcSEcCtD
Glimepiride—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00194	0.00317	CcSEcCtD
Glimepiride—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00194	0.00316	CcSEcCtD
Glimepiride—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00193	0.00315	CcSEcCtD
Glimepiride—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00191	0.00312	CcSEcCtD
Glimepiride—Asthenia—Furosemide—dilated cardiomyopathy	0.00189	0.00309	CcSEcCtD
Glimepiride—Anorexia—Lisinopril—dilated cardiomyopathy	0.00189	0.00308	CcSEcCtD
Glimepiride—Pruritus—Furosemide—dilated cardiomyopathy	0.00187	0.00305	CcSEcCtD
Glimepiride—Hypotension—Lisinopril—dilated cardiomyopathy	0.00185	0.00302	CcSEcCtD
Glimepiride—Diarrhoea—Furosemide—dilated cardiomyopathy	0.0018	0.00295	CcSEcCtD
Glimepiride—Insomnia—Lisinopril—dilated cardiomyopathy	0.00179	0.00292	CcSEcCtD
Glimepiride—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00178	0.0029	CcSEcCtD
Glimepiride—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00176	0.00288	CcSEcCtD
Glimepiride—Somnolence—Lisinopril—dilated cardiomyopathy	0.00176	0.00287	CcSEcCtD
Glimepiride—Dizziness—Furosemide—dilated cardiomyopathy	0.00174	0.00285	CcSEcCtD
Glimepiride—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00174	0.00285	CcSEcCtD
Glimepiride—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00172	0.00281	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00171	0.00279	CcSEcCtD
Glimepiride—Fatigue—Lisinopril—dilated cardiomyopathy	0.00171	0.00279	CcSEcCtD
Glimepiride—Vomiting—Furosemide—dilated cardiomyopathy	0.00168	0.00274	CcSEcCtD
Glimepiride—Rash—Furosemide—dilated cardiomyopathy	0.00166	0.00272	CcSEcCtD
Glimepiride—Dermatitis—Furosemide—dilated cardiomyopathy	0.00166	0.00271	CcSEcCtD
Glimepiride—Headache—Furosemide—dilated cardiomyopathy	0.00165	0.0027	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00165	0.00532	CbGpPWpGaD
Glimepiride—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00163	0.00266	CcSEcCtD
Glimepiride—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00162	0.00264	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00161	0.00518	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00161	0.00518	CbGpPWpGaD
Glimepiride—Urticaria—Lisinopril—dilated cardiomyopathy	0.00157	0.00257	CcSEcCtD
Glimepiride—Nausea—Furosemide—dilated cardiomyopathy	0.00157	0.00256	CcSEcCtD
Glimepiride—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00156	0.00256	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00149	0.00481	CbGpPWpGaD
Glimepiride—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00146	0.00238	CcSEcCtD
Glimepiride—Asthenia—Lisinopril—dilated cardiomyopathy	0.00142	0.00232	CcSEcCtD
Glimepiride—Pruritus—Lisinopril—dilated cardiomyopathy	0.0014	0.00229	CcSEcCtD
Glimepiride—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00135	0.00221	CcSEcCtD
Glimepiride—Dizziness—Lisinopril—dilated cardiomyopathy	0.00131	0.00214	CcSEcCtD
Glimepiride—Vomiting—Lisinopril—dilated cardiomyopathy	0.00126	0.00206	CcSEcCtD
Glimepiride—Rash—Lisinopril—dilated cardiomyopathy	0.00125	0.00204	CcSEcCtD
Glimepiride—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00125	0.00204	CcSEcCtD
Glimepiride—Headache—Lisinopril—dilated cardiomyopathy	0.00124	0.00202	CcSEcCtD
Glimepiride—KCNJ1—Neuronal System—RAF1—dilated cardiomyopathy	0.00119	0.00382	CbGpPWpGaD
Glimepiride—Nausea—Lisinopril—dilated cardiomyopathy	0.00118	0.00192	CcSEcCtD
Glimepiride—ABCC8—Metabolism—ANKRD1—dilated cardiomyopathy	0.00109	0.0035	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ANKRD1—dilated cardiomyopathy	0.00105	0.00339	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00104	0.00335	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—TAZ—dilated cardiomyopathy	0.00102	0.00329	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—TAZ—dilated cardiomyopathy	0.00099	0.00319	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SDHA—dilated cardiomyopathy	0.000923	0.00298	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SDHA—dilated cardiomyopathy	0.000895	0.00289	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000643	0.00207	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—RAF1—dilated cardiomyopathy	0.000606	0.00195	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000605	0.00195	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—RAF1—dilated cardiomyopathy	0.000587	0.00189	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000326	0.00105	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000286	0.000923	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	0.000269	0.000868	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GPX1—dilated cardiomyopathy	0.000251	0.000808	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CD36—dilated cardiomyopathy	0.000244	0.000787	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	0.000244	0.000785	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GPX1—dilated cardiomyopathy	0.000243	0.000784	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CD36—dilated cardiomyopathy	0.000237	0.000763	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AGT—dilated cardiomyopathy	0.00022	0.000709	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AGT—dilated cardiomyopathy	0.000213	0.000687	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000149	0.000479	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000145	0.000466	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.00013	0.00042	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	6.62e-05	0.000213	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	6.44e-05	0.000208	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	5.8e-05	0.000187	CbGpPWpGaD
